Thomas Watkins Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

VNDA Quotes by TradingView

Thomas Watkins is Director of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 63,064 shares of VNDA, which is worth approximately $293,878. The most recent transaction as insider was on Jun 02, 2022, when has been sold 6,441 shares (Common Stock) at a price of $9.9 per share, resulting in proceeds of $63,766. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.1K
0% 3M change
0% 12M change
Total Value Held $293,878

Thomas Watkins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2022
SELL
Open market or private sale
$63,766 $9.9 p/Share
6,441 Reduced 9.27%
63,064 Common Stock
Jun 02 2022
BUY
Exercise of conversion of derivative security
$62,250 $4.15 p/Share
15,000 Added 17.75%
69,505 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 8.4%
54,505 Common Stock
Feb 16 2021
SELL
Open market or private sale
$107,866 $18.54 p/Share
5,818 Reduced 10.52%
49,505 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$106,650 $7.11 p/Share
15,000 Added 21.33%
55,323 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
Director
TW

Thomas Watkins

Director
Dublin, L2

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VNDA